Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...

Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...

Ripple effects from the conflict in the Middle East are felt in San Diego as gas prices increase and the US stock market ...

MercadoLibre looks priced to buy, trading at a forward one-year P/E ratio of 22 and a price-to-free-cash-flow ratio of 15. It may not start soaring until the margins reverse and it reaps the rewards ...

Duolingo continues to add users at a blistering pace. But does a surprising strategic shift and a demanding valuation make ...

IBM’s stock took a hit after Anthropic, the company behind the AI model Claude, said its new tool can make fixing old COBOL ...

Coreweave's stock plummeted 18% on disappointing revenue guidance. The New Jersey-based company also said it plans to spend ...

Nexi (NEXI.MI) stock crashed over 20% to record lows after missing Q4 estimates and issuing 2026 guidance that analysts say ...

Grail (GRAL) stock is plummeting after the company's three-year cancer screening trial failed to meet its main goal ...

CoreWeave (CRWV) stock plunged 28% after missing Q1 revenue guidance and posting widening losses. Citi slashed its price target to $126. Analysis inside.

Novo’s CagriSema shot was shown to be less effective than rival Lilly’s tirzepatide ...